22.418 articles found

THERAPEUTIC AGENTS

GIORDANETTO Fabrizio, INGHARDT Tord.

· 2006-07-13

THERAPEUTIC AGENTS

GIORDANETTO Fabrizio, INGHARDT Tord.

· 2006-07-13

Therapeutic Agents

GIORDANETTO FABRIZIO, INGHARDT TORD, NORDBERG PETER.

· 2006-07-13

Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism.

Emborg ME, Carbon M, Holden JE, During MJ, Ma Y, Tang C, Moirano J, Fitzsimons H, Roitberg BZ, Tuccar E, Roberts A, Kaplitt MG, Eidelberg D.

J Cereb Blood Flow Metab · 2006-07-12

DOI: 10.1038/sj.jcbfm.9600364PMID: 16835631

Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC.

Bankiewicz KS, Forsayeth J, Eberling JL, Sanchez-Pernaute R, Pivirotto P, Bringas J, Herscovitch P, Carson RE, Eckelman W, Reutter B, Cunningham J.

Mol Ther · 2006-07-07

DOI: 10.1016/j.ymthe.2006.05.005PMID: 16829205

NEW COMPOUNDS, PROCESS FOR THEIR PREPARATION, INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF 5-HT6 MEDIATED DISORDERS SUCH AS ALZHEIMER'S DISEASE, COGNITIVE DISORDERS, COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA, OBESITY AND PARKINSON'S DISEASE

NORDVALL Gunnar, PETERSSON Carl, SEHGELMEBLE Fernando.

· 2006-07-03

NEW COMPOUNDS, PROCESS FOR THEIR PREPARATION, INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF 5-HT6 MEDIATED DISORDERS SUCH AS ALZHEIMER¿S DESEASE, COGNITIVE DISORDERS, COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA, OBESITY AND PARKINSON¿S DISEASE

NORDVALL Gunnar, SEHGELMEBLE Fernando.

· 2006-07-03

NEW COMPOUNDS, PROCESS FOR THEIR PREPARATION, INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF 5-HT6 MEDIATED DISORDERS SUCH AS ALZHEIMER S DESEASE, COGNITIVE DISORDERS, COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA, OBESITY AND PARKINSON'S DISEASE

NORDVALL GUNNAR, SEHGELMEBLE FERNANDO.

· 2006-07-03

NEW COMPOUNDS, PROCESS FOR THEIR PREPARATION, INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF 5-HT6 MEDIATED DISORDERS SUCH AS ALZHEIMER'S DISEASE, COGNITIVE DISORDERS, COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA, OBESITY AND PARKINSON'S DISEASE

NORDVALL GUNNAR, PETERSSON CARL, SEHGELMEBLE FERNANDO.

· 2006-07-03

Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease

NORDVALL GUNNAR, SEHGELMEBLE FERNANDO.

· 2006-07-03

Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease

NORDVALL GUNNAR, PETERSSON CARL, SEHGELMEBLE FERNANDO.

· 2006-07-03

New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-HT6 mediated disorders such as alzheimer desease, cognitive disorders, cogn

GUNNAR NORDVALL, CARL PETERSSON, FERNANDO SEHGELMEBLE.

· 2006-07-03